Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Semtech's (SMTC) Q3 Earnings Beat, Sales Miss, View Weak

Published 11/30/2017, 10:17 PM
Updated 07/09/2023, 06:31 AM

Semtech Corporation (NASDAQ:SMTC) reported mixed fiscal third-quarter 2018 results with earnings beating the Zacks Consensus Estimate but revenues missing the same.

Non-GAAP earnings of 54 cents per share beat the consensus mark by 5 cents and increased 12.5% sequentially and a massive 45.9% year over year. Earnings came ahead of the guided range of 48–52 cents per share.

Revenues of $150 million missed the consensus mark by $3 million and decreased 1.8% sequentially. However, revenues increased 9.6% year over year. Revenues were toward the higher end of the guided range of $145.0 million to $153.0 million.

Nevertheless, shares have lost 6.8% since the date of release of quarterly results due to an unimpressive guidance for the current quarter. Year to date, shares have gained 7.9%, significantly underperforming the industry’s 23.2% rally.

In the reported quarter, the company saw strong demand for high-end consumer and industrial end-markets, partially offset by weakness in enterprise computing and communications markets.

The company’s improved profitability was driven by differentiated growth drivers and diversification strategy. Key growth drivers for Semtech are product differentiation, operational flexibility and a specific focus on fast-growing segments and regions.

The numbers in detail:

Revenues by End Market

Sales to high-end consumer market represented 30% of total net revenues and were up sequentially. Roughly 23% of high-end consumer revenues were attributable to mobile devices, and 7% to other consumer systems.

Sales to industrial market represented 28% of total revenues and were up sequentially. Enterprise computing and communications end markets witnessed weak demand and both decreased sequentially, representing 31% and 11% of total revenues, respectively.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Revenues by Product Group

Signal Integrity Product Group revenues contributed 41% to total revenues and were down sequentially but up 6% year over year. While the sequential decline was due to weak passive optical network (PON) and base station business resulting from demand softness in China, the year-over-year growth was driven by strength in data center business.

Protection Product Group represented 32% of total revenues and was up 10% sequentially and 23% year over year. The increase was driven by smartphone strength in North America and Korea offset by softness in China’s smartphone market.

Wireless and Sensing Product Group was down sequentially but up 29% year over year, contributing 20% to total revenues. The year-over-year increase was driven by strength in LoRa related business, partially offset by weakness in proximity sensing business.

Power and High-Reliability Product Group contributed 8% to total revenues and increased 7% sequentially. The increase was due to increased designing activity in the automotive and industrial markets.

Distribution sales represented approximately 66% of total revenues, while direct sales accounted for the remaining 34%.

Semtech Corporation Revenue (TTM)

Bookings

During the quarter, bookings increased sequentially, accounting for roughly 50% of shipments. Book-to-bill ratio was roughly 1.

Margins and Net Income

Non-GAAP gross margin was 61.3%, up 10 basis points (bps) sequentially and 90 bps year over year due to the impact of lower inventory adjustments offset by less favorable product mix.

Semtech’s operating expenses (selling, general and administrative [SG&A] plus product development and engineering) of $53.2 million increased slightly sequentially and 2.5% year over year. As a percentage of sales, both SG&A and product development & engineering expenses decreased year over year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The net result was an operating margin of 27.4% that was flat sequentially but increased 380 bps year over year.

On a non-GAAP basis, Semtech recorded net income of $36.5 million compared with $24.4 million a year ago. On a GAAP basis, the company recorded net income of $13.3 million or 20 cents per share compared with $30.8 million or 46 cents per share a year ago.

Balance Sheet & Cash Flow

Semtech ended the quarter with cash and cash equivalents of $291.1 million, up from $277.9 million in the previous quarter. Accounts receivables were $66.5 million, up from $61.2 million in the prior quarter. Long-term debt was $215.7 million, down from $219.3 million in the previous quarter.

During the quarter, cash flow from operations was $26.9 million, capital expenditure was $7.9 million and free cash flow totaled $19 million.

Guidance

For fiscal fourth quarter 2018, on a non-GAAP basis, management expects revenues in the range of $138 million to $142 million. This implies 7.1% sequential decline at the mid-point of the guided range. The Zacks Consensus Estimate is pegged at $151.0 million.

Non-GAAP gross profit margin is expected within 61.0%-62.0%. Management projects SG&A expense within $26-$27 million, and research and development expense of $23-$24 million.

Non-GAAP earnings per share are expected in the range of 40–42 cents. This implies a massive 31.7% sequential decline at the mid-point of the guided range. The Zacks Consensus Estimate is pegged at 47 cents.

Zacks Rank and Stocks to Consider

Semtech has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Better-ranked stocks in the broader technology sector include Activision Blizzard (NASDAQ:ATVI) , Twitter (NYSE:TWTR) and Five9 (NASDAQ:FIVN) , each carrying a Zacks Rank #2 (Buy).

Long-term earnings per share growth rate for Activision, Twitter and Alibaba (NYSE:BABA) is projected to be 13.8%, 21.5% and 20%, respectively.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



Five9, Inc. (FIVN): Free Stock Analysis Report

Twitter, Inc. (TWTR): Free Stock Analysis Report

Activision Blizzard, Inc (ATVI): Free Stock Analysis Report

Semtech Corporation (SMTC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.